KIT mutations and imatinib dose effects in patients with gastrointestinal stromal tumors.

Article Details

Citation

Copy to clipboard

De Giorgi U

KIT mutations and imatinib dose effects in patients with gastrointestinal stromal tumors.

J Clin Oncol. 2007 Mar 20;25(9):1146-7; author reply 1147-8.

PubMed ID

17369583 [ View in PubMed

]

Abstract

Not Available

DrugBank Data that Cites this Article

Drug Targets

Drug	Target	Kind	Organism	Pharmacological Action	Actions
Imatinib	Mast/stem cell growth factor receptor Kit	Protein	Humans	Yes	Antagonist	Details